Royalty Pharma PLC (RPRX)
28.16
+0.28
(+1.00%)
USD |
NASDAQ |
Apr 19, 16:00
28.16
0.00 (0.00%)
After-Hours: 18:12
Royalty Pharma Total Assets (Quarterly): 16.38B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 16.38B |
| September 30, 2023 | 15.86B |
| June 30, 2023 | 17.12B |
| March 31, 2023 | 17.07B |
| December 31, 2022 | 16.81B |
| September 30, 2022 | 17.67B |
| June 30, 2022 | 17.74B |
| March 31, 2022 | 17.38B |
| December 31, 2021 | 17.52B |
| Date | Value |
|---|---|
| September 30, 2021 | 17.73B |
| June 30, 2021 | 16.51B |
| March 31, 2021 | 15.91B |
| December 31, 2020 | 16.02B |
| September 30, 2020 | 15.99B |
| June 30, 2020 | 15.69B |
| March 31, 2020 | 13.37B |
| December 31, 2019 | 12.45B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
12.45B
Minimum
Dec 2019
17.74B
Maximum
Jun 2022
16.31B
Average
16.51B
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Viatris Inc | 47.69B |
| Walgreens Boots Alliance Inc | 84.21B |
| Pacira BioSciences Inc | 1.574B |
| Amphastar Pharmaceuticals Inc | 1.513B |
| Maravai LifeSciences Holdings Inc | 1.487B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.298B |
| Shareholders Equity (Quarterly) | 6.526B |
| Debt to Equity Ratio | 0.9401 |
| Current Ratio | 7.896 |
| Net Debt Paydown Yield | 1.56% |